The high price of lifesaving tuberculosis drugs makes them inaccessible to many who need them most. On this episode of “An Arm and a Leg,” hear how a decades-long global fight to reform drug patents is helping to lower the cost.
The high price of lifesaving tuberculosis drugs makes them inaccessible to many who need them most. On this episode of “An Arm and a Leg,” hear how a decades-long global fight to reform drug patents is helping to lower the cost.
The Greens were not alone in calling for J&J to not enforce its secondary patents on the TB drug as Doctors Without Borders issued a similar request in late April.
The drug manufacturer faced an online pressure campaign championed by novelist John Green before the announcement Thursday, which lets Stop TB Partnership offer cheaper generic versions of Johnson & Johnson’s tuberculosis drug in 44 more countries.